EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Gentrogroup Co. Ltd. (083660) fair value: what the stock is really worth

We calculate from audited financials what Gentrogroup Co. Ltd. is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Non-Cyclicals · KR · ISIN KR7083660001

GC Thin data Sep 13, 2026

Gentrogroup Co. Ltd.

083660 · KQ

Weakest SetupStrongly overvalued and low quality.

!Fair value 255.07 KRW · Strongly overvalued (−83%)
!Quality 25/100
!Weak Growth (revenue 5y −13.7 %/yr)
!Loss-making · -4.8% net margin (TTM)
!Low debt · negative free cash flow
!Trails peers (2/7)
!Narrow moat 14/100
!Evidence only low, so the estimate is less certain
!Weak on future: 29 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

24,150 KRW 1,350 KRW Fair Value 255.07 KRW Feb 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

60‑month range 1,350 KRW – 24,150 KRW · fair‑value band 168.35 KRW – 318.84 KRW · the 1,486 KRW price screens above the 255.07 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Csa Cosmic Co., Ltd. engages in the manufacture and sale of cosmetics in South Korea. It is also involved in the manufacturing construction materials, as well as in the specialized construction works. The company was founded in 1989 and is headquartered in Seoul, South Korea.

Stock analysis

Gentrogroup Co. Ltd. (083660) currently trades at 1,486 KRW, while our model-based Fair Value estimate is 255.07 KRW, implying the stock looks roughly 482.8% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: 168.35 KRW (bear) to 318.84 KRW (bull), the price of 1,486 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 25/100 (below-average quality), in the Consumer Non-Cyclicals sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Gentrogroup Co. Ltd. reported revenue of 27.9B KRW in FY2025 versus 60.3B KRW in FY2021, a compound −17.5%/yr. Reported net income was −6.7B KRW in FY2025.

Key figures

Market cap 24.5B KRW (≈ $17.2M) · P/S ratio 0.61 · Net margin −23.9% · Return on equity −2,733% · Return on assets (EBIT) −14.3% · Operating margin −1.9% · Revenue (TTM) 69.1B KRW · Revenue growth (YoY) +5.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).

What moves the price

The share trades about 48% below its 52-week high, currently above its 200-day average.

For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at −16% fair-value upside, at −83%, 083660 screens richer than that median.

Fair Value models

Bear 168.35 KRW Fair Value 255.07 KRW Bull 318.84 KRW
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 419.63 KRW 562.30 KRW 839.25 KRW 54
All 1 models by family
Asset-Based
NCAV (Graham) 419.63 KRW 562.30 KRW 839.25 KRW 54

Open the full fair value analysis →

Notify me when 083660 reaches fair value

Put 083660 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 25/100

Of which business quality 28 · Market factors (momentum, volatility) 23

Profitability 26
Margins and returns on capital today
Quality Growth 22
Are margins and returns improving?
Cashflow 4
Earnings quality: real cash, not paper profit
Fin. Strength 59
Balance sheet, leverage, solvency risk
Investment 63
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 30
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−23.2%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−23.0%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.7%
Revenue growth 14 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.5%
Profit margin (trend) Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−16.6% (2020) → −20.2% (2025)
What shareholders gained per year We only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

083660 screens 483% overvalued. Compare with NeoPharm CO., LTD. →

Compare Gentrogroup Co. Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Personal & Household Products & Services” was too small, so the broader sector is used.)Industrials · 5508 stocks

Beats the sector median on 2/7 measures
Overall it trails its sector peers.
Valuation
Quality Score 28 · Bottom 25%
Fair Value upside −84% · Bottom 25%
Profitability
Return on assets −2% · Bottom 25%
Net margin (TTM) −5% · Bottom 25%
Operating margin (TTM) −2% · Bottom 25%
Growth and dividend
Revenue growth 6% · Above median
Balance sheet
Debt / equity 0.01× · Lowest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 14
FUTURE (revenue growth)29 · sector 23
PAST (return on equity)0 · sector 26
HEALTH (low debt)100 · sector 94
DIVIDEND (yield)0 · sector 35

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Personal & Household Products & Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
NeoPharm CO., LTD. 092730 21,600 KRW 35,793 KRW +66%
HYUNDAI BIOLAND Co 052260 3,980 KRW 2,740 KRW −31%
AUX AUX 1.18 PLN 0.3900 PLN −67%
FB FB 46.00 PHP 38.80 PHP −16%
JGS JGS 19.16 PHP 20.34 PHP +6%
URC URC 58.15 PHP 38.87 PHP −33%
SMC SMC 62.80 PHP 45.17 PHP −28%
MONDE MONDE 6.91 PHP 0.8100 PHP −88%
PGOLD PGOLD 40.00 PHP 49.55 PHP +24%
RRHI RRHI 38.00 PHP 38.74 PHP +2%

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Gentrogroup Co. Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/083660

Frequently asked questions

Is Gentrogroup Co. Ltd. (083660) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 255.07 KRW versus a price of 1,486 KRW, about −83% upside (overvalued).
What is the fair value of 083660?
Our model-based fair value for Gentrogroup Co. Ltd. is 255.07 KRW (as of Sep 13, 2026), built from audited fundamentals. The current price: 1,486 KRW.
What is the quality score of 083660?
Gentrogroup Co. Ltd. has a Quality Score of 25/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Gentrogroup Co. Ltd. (083660)?
Our model-based price target is the fair value of 255.07 KRW (as of Sep 13, 2026) from 1 valuation models. Cautious scenario 168.35 KRW, optimistic scenario 318.84 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Gentrogroup Co. Ltd. stock forecast for 2026?
Our models put fair value at 255.07 KRW, about −83% upside versus a price of 1,486 KRW (overvalued). Cautious scenario 168.35 KRW, optimistic scenario 318.84 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Gentrogroup Co. Ltd. (083660)?
Gentrogroup Co. Ltd. reported trailing-twelve-month revenue of about 69.1B KRW (latest available figure, as of Sep 13, 2026).
What is the intrinsic value of Gentrogroup Co. Ltd. (083660)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Gentrogroup Co. Ltd. it is 255.07 KRW per share (as of Sep 13, 2026), against a price of 1,486 KRW. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Gentrogroup Co. Ltd. stock overvalued or undervalued in 2026?
As of Sep 13, 2026, 083660 trades above its calculated fair value: price 1,486 KRW, fair value 255.07 KRW, a gap of about −83% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 083660?
No. The price is what the market pays today (1,486 KRW); the fair value is what the company's own numbers justify (255.07 KRW). For Gentrogroup Co. Ltd. the two are 1,231 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Gentrogroup Co. Ltd. worth?
The market values Gentrogroup Co. Ltd. at about 24.5B KRW (market capitalisation, as of Sep 13, 2026). Per share that is 1,486 KRW; our models calculate a fair value of 255.07 KRW per share.
What do the bullish and bearish scenarios say about 083660?
Our models span a range for Gentrogroup Co. Ltd.: cautious scenario 168.35 KRW, base 255.07 KRW, optimistic 318.84 KRW per share (as of Sep 13, 2026, price 1,486 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Gentrogroup Co. Ltd. (083660)?
Balance-sheet figures for Gentrogroup Co. Ltd. (as of Sep 13, 2026): debt of 0.01 per unit of equity. They feed the Quality Score of 25/100, which measures business quality independently of the share price.
How far is 083660 from its 52-week high?
Gentrogroup Co. Ltd. trades at 1,486 KRW, about 48% below its 52-week high of 2,885 KRW and 726% above the low of 180.00 KRW (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 255.07 KRW is for.
Which stocks are comparable to Gentrogroup Co. Ltd.?
From the same area (Consumer Non-Cyclicals) we also value NeoPharm CO., LTD., HYUNDAI BIOLAND Co, AUX, FB, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Gentrogroup Co. Ltd. stock attractive at the current price?
The data as of Sep 13, 2026: price 1,486 KRW, calculated fair value 255.07 KRW (−83%), Quality Score 25/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 083660 calculated?
We run Gentrogroup Co. Ltd. through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 255.07 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Gentrogroup Co. Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Gentrogroup Co. Ltd. right now?
The price sits above even our optimistic bull case (318.84 KRW). The favourable scenario is already priced in. Weak quality (25/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (168.35 KRW to 318.84 KRW) leaves room in how you read the outcome.

Key figures of Gentrogroup Co. Ltd.

How large is the market capitalisation of Gentrogroup Co. Ltd. (083660)?
The market capitalisation of Gentrogroup Co. Ltd. is 24.5B KRW (≈ $17.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Gentrogroup Co. Ltd. (083660)?
The price-to-sales ratio of Gentrogroup Co. Ltd. is 0.61 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Gentrogroup Co. Ltd. (083660)?
The net margin of Gentrogroup Co. Ltd. is −23.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Gentrogroup Co. Ltd. (083660)?
The return on equity (ROE) of Gentrogroup Co. Ltd. is −2,733% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Gentrogroup Co. Ltd. (083660)?
On an EBIT basis the return on assets of Gentrogroup Co. Ltd. is −14.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Gentrogroup Co. Ltd. (083660)?
The operating margin of Gentrogroup Co. Ltd. is −1.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Gentrogroup Co. Ltd. (083660)?
Revenue at Gentrogroup Co. Ltd. is growing +5.7% versus a year earlier (3y avg −23.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Gentrogroup Co. Ltd. (083660) generate?
The free cash flow of Gentrogroup Co. Ltd. is −5.6B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Gentrogroup Co. Ltd. (083660) carry?
The net debt of Gentrogroup Co. Ltd. is 615M KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Gentrogroup Co. Ltd. in the live analysis

One click puts Gentrogroup Co. Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.